Myasthenia gravis trials in Australia
6 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- Where
- North Melbourne, Southport
- Age
- 18 years and over
- People
- 199 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT04951622 · EU 2023-504152-97-00 - Phase 3Taking peopleEfficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
- Where
- Birtinya, Box Hill, Camperdown, City of Burnside, South Brisbane, Southport
- Age
- 18 years and over
- People
- 264 worldwide
- Run by
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
See details and how to joinNCT06463587 · EU 2023-507746-83-00 - Phase 1Taking peopleStudy of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
- Where
- Sydney, Westmead
- Age
- 18 years to 75 years
- People
- 57 worldwide
- Run by
- Kite, A Gilead Company
See details and how to joinNCT07304154 - Phase 2/3Taking peopleA Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis
- Where
- Melbourne, Randwick
- Age
- 2 years to 17 years
- People
- 12 worldwide
- Run by
- argenx
See details and how to joinNCT06392386 · EU 2023-506159-12-00 - Phase 2/3Taking peopleKYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Where
- Westmead
- Age
- 18 years to 75 years
- People
- 66 worldwide
- Run by
- Kyverna Therapeutics
See details and how to joinNCT06193889 · EU 2023-509892-17-00 - No phaseTaking peopleStudy of Ultomiris® (Ravulizumab) Safety in Pregnancy
- Where
- Melbourne
- People
- 75 worldwide
- Run by
- Alexion Pharmaceuticals, Inc.
See details and how to joinNCT06312644